Editor Ben Weinberg

About the Author Editor Ben Weinberg


UBS Reiterates Neutral On Exxon Mobil Following Investor Meetings

In a research report published this morning, UBS analyst William Featherston reiterated a Neutral rating …

Read more

Credit Suisse Reiterates Underperform On Blackberry Ahead Of 3Q15 Results

In a research report┬áreleased today, Credit Suisse analyst Kulbinder Garcha reiterated an Underperform rating on …

Read more

Evercore Maintains Hold On Spirit Airlines Shares, $85 PT

In a research report published today, Evercore ISI analyst Duane Pfennigwerth maintained a Hold rating …

Read more

Prospect Capital: We Do Not Believe Current Levels Are An Attractive Entry Point, Says Wells Fargo

In a research report released today, Wells Fargo analyst Jonathan Bock reaffirmed a Market Perform …

Read more

H.C. Wainwright Reaffirms Buy On Synthetic Biologics, Sees 186% Upside

In a research report published today, H.C. Wainwright analyst Andrew Fein reaffirmed a Buy rating …

Read more

RXi Pharmaceuticals Represents An Undervalued Player With Significant Upside, Says H.C. Wainwright

In a research note issued today, H.C. Wainwright analyst Reni Benjamin reiterated a Buy rating …

Read more

Cantor Fitzgerald Reaffirms Buy On Threshold Pharmaceuticals Following Strong GBM Data

In a research note released today, Cantor Fitzgerald analyst Daniel Brims reaffirmed a Buy rating …

Read more

Cantor Fitzgerald Maintains Hold On Sunesis Pharma, Sees 6% Downside For The Stock

In a research note published this morning, Cantor Fitzgerald analyst Mara Goldstein maintained a Hold …

Read more

H.C. Wainwright Reiterates Buy On Capricor Following 3Q14 Results

In a research note issued today, H.C. Wainwright analyst Reni Benjamin reiterated a Buy rating …

Read more

GenVec Represents An Undervalued Innovator In The Gene Therapy Arena, Says H.C. Wainwright

In a research note published today, H.C. Wainwright analyst Reni Benjamin reiterated a Buy rating …

Read more